Rocky Mountain Analytical
A division of LifeLabs, RMA provides specialized tests to naturopathic doctors, physicians and other healthcare providers who practice integrative medicine.
Hemostasis Reference Laboratory (HRL)
HRL became a LifeLabs division following LifeLabs’ acquisition of CML HealthCare Inc. HRL provides quality coagulation testing services to international customers.
LifeLabs Genetics offers more than 2,000 genetic and biochemical tests.
In February 2014, LifeLabs acquired the Canadian business of Centogene, a German molecular diagnostic laboratory. Receiving samples from more than 90 countries, Centogene is a world leader in molecular diagnostics. With a comprehensive database and medical expertise, the company provides patients with quality diagnostic reporting and medical interpretation of genetic information.
A B.C.-based company, Contextual Genomics provides molecular information to guide patient decisions. In April 2014, LifeLabs entered into an agreement with Contextual Genomics to co-market and offer tests for cancer and other genetic and genomic tests.
Natera is a genetic testing and diagnostics company with proprietary bioinformatics and molecular technology. LifeLabs became a Canadian distributor of the Panorama Non-Invasive Prenatal Test (NIPT) in September 2013 and acquired the rights to perform the Panorama NIPT in Canada using Natera’s technology in April 2015.
NanoString Technologies is a publicly held provider of life science tools for translational research and molecular diagnostics. In March 2015, LifeLabs announced a partnership with NanoString to offer Prosigna, a test that can help determine the likelihood of cancer recurrence from breast tumour tissue.
Counsyl is a health technology company that offers DNA screening for men, women, and their children. In April 2015, LifeLabs began offering the Counsyl Family Prep Screen, a genetic test that can determine whether individuals and couples are carriers of over 100 hereditary health conditions for informed family planning.
Phenomenome Discoveries Inc. (PDI) is a health research company with a novel and patented metabolomics technology. LifeLabs partners with Phenomenome to offer both Alz-ID, a blood test for determining risk of Alzheimer’s disease, and COLOGIC, a blood test used to assess the risk of colorectal (colon) cancer.
Excelleris Technologies Inc.
A wholly owned subsidiary of LifeLabs, Excelleris delivers electronic health-care information and laboratory results to healthcare providers and patients.